Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Jul 09, 2020

SELL
$25.95 - $43.15 $1,557 - $2,589
-60 Closed
0 $0
Q1 2020

Apr 16, 2020

BUY
$26.15 - $77.24 $1,569 - $4,634
60 New
60 $2,000
Q4 2019

Jan 17, 2020

SELL
$60.18 - $154.77 $91,774 - $236,024
-1,525 Closed
0 $0
Q3 2019

Oct 09, 2019

BUY
$140.29 - $189.96 $140 - $189
1 Added 0.07%
1,525 $214,000
Q2 2019

Jul 23, 2019

BUY
$157.85 - $183.09 $240,563 - $279,029
1,524 New
1,524 $279,000

Others Institutions Holding SAGE

About Sage Therapeutics, Inc.


  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $323M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Arden Trust CO Portfolio

Follow Arden Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arden Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Arden Trust CO with notifications on news.